Latest News

The Indo-US Chamber of Commerce honors TransGenex founder with the International Business Person of the Year Award....more

TransGenex Nanobiotech Inc. profiled in "The In Vivo Blog"....more
The future of nanomedicine . . . today

TransGenex Nanobiotech, Inc. (TGN), is a Florida-based biotechnology company incorporated in 2004. Its mission is:

  • to develop ultra-sensitive, nanoparticle-based technology platforms for early disease detection

  • to discover and develop nanoparticle formulations and nano-encapsulation methods for use against novel targets to treat acute and chronic lung diseases and cancers

© Copyright 2003, TransGenex Nanobiotech (see Website Agreement)